002287.SZ
002287.SZ
CNE100000FM9
CHEEZHENGTTM
Loading chart...

Company Profile

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral Tibetan and traditional Chinese medicine products, external analgesics, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculoskeletal system, nervous system, respiratory, digestive, urinary, and cerebrovascular sectors. The company was founded in 1995 and is headquartered in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

Related stocks

2595.HK
2595.HK • China
GENFLEET-B
28.6 HKD
1.4B USD 1Y -21%
688382.SS
688382.SS • China
INVENTISBIO CO LTD
17.26 CNY
1.5B USD 1Y -42.5%
1952.HK
1952.HK • China
EVEREST MED
29.6 HKD
1.33B USD 1Y -47.1%
9606.HK
9606.HK • China
DUALITYBIO-B
182.7 HKD
2.13B USD 1Y -42.1%
688166.SS
688166.SS • China
BRIGHTGENE BIO-MEDICAL TECHNOLO
33.53 CNY
2.19B USD 1Y -41.8%
9887.HK
9887.HK • China
LEADS BIOLABS-B
45.56 HKD
1.15B USD 1Y -37.5%
300204.SZ
300204.SZ • China
STAIDSON BIO
20.66 CNY
1.67B USD 1Y -38.7%
300009.SZ
300009.SZ • China
ANKEBIO
8.53 CNY
2.13B USD 1Y -17.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.9% p.a.
Max Drawdown (5Y)
-48.5%
Sharpe Ratio (5Y)
-0.38
Beta Factor
0.20
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -64.4% in the extended horizon.
ende